nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—psoriasis—systemic lupus erythematosus	0.738	1	CtDrD
Tazarotene—CYP2C8—Dapsone—systemic lupus erythematosus	0.0259	0.274	CbGbCtD
Tazarotene—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0224	0.237	CbGbCtD
Tazarotene—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.018	0.191	CbGbCtD
Tazarotene—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.017	0.18	CbGbCtD
Tazarotene—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0112	0.118	CbGbCtD
Tazarotene—Application site dryness—Dapsone—systemic lupus erythematosus	0.00999	0.107	CcSEcCtD
Tazarotene—Phototoxicity—Dapsone—systemic lupus erythematosus	0.00601	0.0644	CcSEcCtD
Tazarotene—Application site erythema—Dapsone—systemic lupus erythematosus	0.00489	0.0524	CcSEcCtD
Tazarotene—Application site pruritus—Dapsone—systemic lupus erythematosus	0.00472	0.0506	CcSEcCtD
Tazarotene—Localized exfoliation—Dapsone—systemic lupus erythematosus	0.00428	0.0459	CcSEcCtD
Tazarotene—Application site pain—Dapsone—systemic lupus erythematosus	0.00262	0.0281	CcSEcCtD
Tazarotene—RXRB—Vitamin D Metabolism—RXRA—systemic lupus erythematosus	0.00192	0.0331	CbGpPWpGaD
Tazarotene—RXRB—Vitamin D Metabolism—VDR—systemic lupus erythematosus	0.00174	0.03	CbGpPWpGaD
Tazarotene—Application site irritation—Hydrocortisone—systemic lupus erythematosus	0.00152	0.0163	CcSEcCtD
Tazarotene—Localized exfoliation—Triamcinolone—systemic lupus erythematosus	0.00147	0.0158	CcSEcCtD
Tazarotene—RARG—skin of body—systemic lupus erythematosus	0.00115	0.0698	CbGeAlD
Tazarotene—Skin exfoliation—Dapsone—systemic lupus erythematosus	0.0011	0.0118	CcSEcCtD
Tazarotene—Cheilitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00109	0.0117	CcSEcCtD
Tazarotene—RARB—tendon—systemic lupus erythematosus	0.00107	0.0651	CbGeAlD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.00104	0.0179	CbGpPWpGaD
Tazarotene—RARA—kidney—systemic lupus erythematosus	0.00102	0.0619	CbGeAlD
Tazarotene—Leukoderma—Prednisolone—systemic lupus erythematosus	0.00102	0.0109	CcSEcCtD
Tazarotene—Leukoderma—Hydrocortisone—systemic lupus erythematosus	0.000992	0.0106	CcSEcCtD
Tazarotene—RXRB—tendon—systemic lupus erythematosus	0.000986	0.0599	CbGeAlD
Tazarotene—Skin irritation—Hydrocortisone—systemic lupus erythematosus	0.000975	0.0105	CcSEcCtD
Tazarotene—Application site pain—Hydrocortisone—systemic lupus erythematosus	0.000959	0.0103	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000944	0.0162	CbGpPWpGaD
Tazarotene—RARB—lung—systemic lupus erythematosus	0.000941	0.0572	CbGeAlD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000935	0.0161	CbGpPWpGaD
Tazarotene—Leukoderma—Triamcinolone—systemic lupus erythematosus	0.000934	0.01	CcSEcCtD
Tazarotene—Leukoderma—Methylprednisolone—systemic lupus erythematosus	0.000932	0.01	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.00093	0.016	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000896	0.0154	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000896	0.0154	CbGpPWpGaD
Tazarotene—CYP2C8—blood plasma—systemic lupus erythematosus	0.000891	0.0541	CbGeAlD
Tazarotene—RARA—lymphoid tissue—systemic lupus erythematosus	0.000875	0.0532	CbGeAlD
Tazarotene—RARG—tendon—systemic lupus erythematosus	0.000875	0.0531	CbGeAlD
Tazarotene—RXRB—lung—systemic lupus erythematosus	0.000865	0.0525	CbGeAlD
Tazarotene—Leukoderma—Betamethasone—systemic lupus erythematosus	0.000848	0.00909	CcSEcCtD
Tazarotene—Leukoderma—Dexamethasone—systemic lupus erythematosus	0.000848	0.00909	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000847	0.0146	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000842	0.0145	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.000834	0.0143	CbGpPWpGaD
Tazarotene—Hypertriglyceridaemia—Cyclosporine—systemic lupus erythematosus	0.000827	0.00886	CcSEcCtD
Tazarotene—RARA—tendon—systemic lupus erythematosus	0.000823	0.05	CbGeAlD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000812	0.014	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000812	0.014	CbGpPWpGaD
Tazarotene—RXRB—nervous system—systemic lupus erythematosus	0.000801	0.0487	CbGeAlD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.000799	0.0137	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—RXRA—systemic lupus erythematosus	0.000799	0.0137	CbGpPWpGaD
Tazarotene—RARA—bone marrow—systemic lupus erythematosus	0.000797	0.0484	CbGeAlD
Tazarotene—RXRB—central nervous system—systemic lupus erythematosus	0.000771	0.0468	CbGeAlD
Tazarotene—RARG—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000769	0.0132	CbGpPWpGaD
Tazarotene—RARG—lung—systemic lupus erythematosus	0.000768	0.0466	CbGeAlD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000762	0.0131	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000755	0.013	CbGpPWpGaD
Tazarotene—Leukoderma—Prednisone—systemic lupus erythematosus	0.000738	0.00792	CcSEcCtD
Tazarotene—Acne—Leflunomide—systemic lupus erythematosus	0.000731	0.00784	CcSEcCtD
Tazarotene—Blood triglycerides increased—Cyclosporine—systemic lupus erythematosus	0.000724	0.00777	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000724	0.0124	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—VDR—systemic lupus erythematosus	0.000724	0.0124	CbGpPWpGaD
Tazarotene—RARA—lung—systemic lupus erythematosus	0.000722	0.0438	CbGeAlD
Tazarotene—RARG—nervous system—systemic lupus erythematosus	0.000711	0.0432	CbGeAlD
Tazarotene—Skin hyperpigmentation—Hydrocortisone—systemic lupus erythematosus	0.000709	0.00761	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000697	0.012	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000697	0.012	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.00069	0.0119	CbGpPWpGaD
Tazarotene—RARG—central nervous system—systemic lupus erythematosus	0.000685	0.0416	CbGeAlD
Tazarotene—Burning sensation—Cyclosporine—systemic lupus erythematosus	0.000683	0.00733	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000683	0.0117	CbGpPWpGaD
Tazarotene—Skin discolouration—Leflunomide—systemic lupus erythematosus	0.000681	0.0073	CcSEcCtD
Tazarotene—RARA—nervous system—systemic lupus erythematosus	0.000669	0.0406	CbGeAlD
Tazarotene—Skin hyperpigmentation—Triamcinolone—systemic lupus erythematosus	0.000668	0.00716	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—systemic lupus erythematosus	0.000666	0.00715	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000662	0.0114	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000662	0.0114	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Dapsone—systemic lupus erythematosus	0.00066	0.00708	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000658	0.0113	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000655	0.0113	CbGpPWpGaD
Tazarotene—RARA—central nervous system—systemic lupus erythematosus	0.000644	0.0391	CbGeAlD
Tazarotene—Inflammation—Leflunomide—systemic lupus erythematosus	0.000634	0.0068	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000627	0.0108	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000625	0.0107	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000625	0.0107	CbGpPWpGaD
Tazarotene—Leukoderma—Methotrexate—systemic lupus erythematosus	0.000617	0.00662	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000608	0.0105	CbGpPWpGaD
Tazarotene—Dermatitis contact—Leflunomide—systemic lupus erythematosus	0.000608	0.00652	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—systemic lupus erythematosus	0.000606	0.0065	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Betamethasone—systemic lupus erythematosus	0.000606	0.0065	CcSEcCtD
Tazarotene—Blister—Prednisolone—systemic lupus erythematosus	0.000599	0.00643	CcSEcCtD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000599	0.0103	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—RXRA—systemic lupus erythematosus	0.000599	0.0103	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000599	0.0103	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000599	0.0103	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.00059	0.0102	CbGpPWpGaD
Tazarotene—Stinging—Cyclosporine—systemic lupus erythematosus	0.000586	0.00628	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—RXRA—systemic lupus erythematosus	0.000578	0.00994	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000566	0.00973	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000566	0.00973	CbGpPWpGaD
Tazarotene—Acne—Cyclosporine—systemic lupus erythematosus	0.000564	0.00605	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000563	0.00967	CbGpPWpGaD
Tazarotene—Blister—Triamcinolone—systemic lupus erythematosus	0.000551	0.00591	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000551	0.00947	CbGpPWpGaD
Tazarotene—Acne—Mycophenolate mofetil—systemic lupus erythematosus	0.00055	0.0059	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—systemic lupus erythematosus	0.000547	0.00586	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000545	0.00938	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000539	0.00927	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000539	0.00927	CbGpPWpGaD
Tazarotene—Stinging—Prednisolone—systemic lupus erythematosus	0.000533	0.00572	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000531	0.00913	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000523	0.00899	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000523	0.00899	CbGpPWpGaD
Tazarotene—Stinging—Hydrocortisone—systemic lupus erythematosus	0.000521	0.00558	CcSEcCtD
Tazarotene—Acne—Prednisolone—systemic lupus erythematosus	0.000513	0.00551	CcSEcCtD
Tazarotene—Skin discolouration—Mycophenolate mofetil—systemic lupus erythematosus	0.000513	0.0055	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000507	0.00872	CbGpPWpGaD
Tazarotene—Erythema—Dapsone—systemic lupus erythematosus	0.000504	0.0054	CcSEcCtD
Tazarotene—Acne—Hydrocortisone—systemic lupus erythematosus	0.000501	0.00538	CcSEcCtD
Tazarotene—Blister—Dexamethasone—systemic lupus erythematosus	0.0005	0.00536	CcSEcCtD
Tazarotene—Blister—Betamethasone—systemic lupus erythematosus	0.0005	0.00536	CcSEcCtD
Tazarotene—Eczema—Leflunomide—systemic lupus erythematosus	0.000497	0.00533	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000496	0.00852	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000494	0.00849	CbGpPWpGaD
Tazarotene—Stinging—Triamcinolone—systemic lupus erythematosus	0.00049	0.00526	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000486	0.00835	CbGpPWpGaD
Tazarotene—Blood triglycerides increased—Prednisone—systemic lupus erythematosus	0.000479	0.00514	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000476	0.00819	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000474	0.00814	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000474	0.00814	CbGpPWpGaD
Tazarotene—Acne—Triamcinolone—systemic lupus erythematosus	0.000472	0.00506	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—systemic lupus erythematosus	0.000471	0.00505	CcSEcCtD
Tazarotene—Skin discolouration—Hydrocortisone—systemic lupus erythematosus	0.000467	0.00501	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000457	0.00785	CbGpPWpGaD
Tazarotene—Stinging—Dexamethasone—systemic lupus erythematosus	0.000445	0.00477	CcSEcCtD
Tazarotene—Stinging—Betamethasone—systemic lupus erythematosus	0.000445	0.00477	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000445	0.00765	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Methotrexate—systemic lupus erythematosus	0.000441	0.00473	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000436	0.00749	CbGpPWpGaD
Tazarotene—Inflammation—Hydrocortisone—systemic lupus erythematosus	0.000435	0.00466	CcSEcCtD
Tazarotene—Acne—Dexamethasone—systemic lupus erythematosus	0.000428	0.00459	CcSEcCtD
Tazarotene—Acne—Betamethasone—systemic lupus erythematosus	0.000428	0.00459	CcSEcCtD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000426	0.00733	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000426	0.00733	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000418	0.00718	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000418	0.00718	CbGpPWpGaD
Tazarotene—Dermatitis contact—Hydrocortisone—systemic lupus erythematosus	0.000417	0.00447	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.000413	0.00711	CbGpPWpGaD
Tazarotene—Dry skin—Leflunomide—systemic lupus erythematosus	0.000409	0.00439	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—systemic lupus erythematosus	0.000409	0.00438	CcSEcCtD
Tazarotene—CYP2C8—kidney—systemic lupus erythematosus	0.000404	0.0245	CbGeAlD
Tazarotene—Skin exfoliation—Hydrocortisone—systemic lupus erythematosus	0.000403	0.00432	CcSEcCtD
Tazarotene—Dermatitis contact—Triamcinolone—systemic lupus erythematosus	0.000393	0.00421	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.000384	0.0066	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000384	0.0066	CbGpPWpGaD
Tazarotene—Eczema—Cyclosporine—systemic lupus erythematosus	0.000383	0.00411	CcSEcCtD
Tazarotene—Skin exfoliation—Triamcinolone—systemic lupus erythematosus	0.000379	0.00407	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—systemic lupus erythematosus	0.000378	0.00406	CcSEcCtD
Tazarotene—Burning sensation—Methotrexate—systemic lupus erythematosus	0.000378	0.00405	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000374	0.00644	CbGpPWpGaD
Tazarotene—Acne—Prednisone—systemic lupus erythematosus	0.000373	0.004	CcSEcCtD
Tazarotene—Dermatitis bullous—Cyclosporine—systemic lupus erythematosus	0.000361	0.00387	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—systemic lupus erythematosus	0.000356	0.00382	CcSEcCtD
Tazarotene—Dermatitis contact—Betamethasone—systemic lupus erythematosus	0.000356	0.00382	CcSEcCtD
Tazarotene—Dermatitis bullous—Mycophenolate mofetil—systemic lupus erythematosus	0.000352	0.00377	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000349	0.00601	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.000344	0.00592	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000344	0.00592	CbGpPWpGaD
Tazarotene—Skin exfoliation—Betamethasone—systemic lupus erythematosus	0.000344	0.00369	CcSEcCtD
Tazarotene—Skin exfoliation—Dexamethasone—systemic lupus erythematosus	0.000344	0.00369	CcSEcCtD
Tazarotene—Eczema—Hydrocortisone—systemic lupus erythematosus	0.000341	0.00365	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000336	0.00577	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.00033	0.00568	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—EP300—systemic lupus erythematosus	0.00033	0.00568	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.00033	0.00568	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.00033	0.00568	CbGpPWpGaD
Tazarotene—Haemoglobin—Azathioprine—systemic lupus erythematosus	0.000329	0.00353	CcSEcCtD
Tazarotene—Dermatitis bullous—Prednisolone—systemic lupus erythematosus	0.000328	0.00352	CcSEcCtD
Tazarotene—Haemorrhage—Azathioprine—systemic lupus erythematosus	0.000327	0.00351	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000322	0.00553	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000322	0.00553	CbGpPWpGaD
Tazarotene—Dry skin—Cyclosporine—systemic lupus erythematosus	0.000316	0.00339	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000313	0.00539	CbGpPWpGaD
Tazarotene—Haemoglobin—Leflunomide—systemic lupus erythematosus	0.00031	0.00333	CcSEcCtD
Tazarotene—Haemorrhage—Leflunomide—systemic lupus erythematosus	0.000309	0.00331	CcSEcCtD
Tazarotene—Oedema peripheral—Leflunomide—systemic lupus erythematosus	0.000304	0.00326	CcSEcCtD
Tazarotene—Dermatitis bullous—Triamcinolone—systemic lupus erythematosus	0.000302	0.00324	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000301	0.00517	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000301	0.00517	CbGpPWpGaD
Tazarotene—Skin exfoliation—Prednisone—systemic lupus erythematosus	0.0003	0.00321	CcSEcCtD
Tazarotene—RARA—Adipogenesis—GADD45A—systemic lupus erythematosus	0.000299	0.00515	CbGpPWpGaD
Tazarotene—Skin discolouration—Methotrexate—systemic lupus erythematosus	0.00029	0.00311	CcSEcCtD
Tazarotene—RARA—Adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000289	0.00496	CbGpPWpGaD
Tazarotene—Dry skin—Prednisolone—systemic lupus erythematosus	0.000287	0.00308	CcSEcCtD
Tazarotene—Dry skin—Hydrocortisone—systemic lupus erythematosus	0.000281	0.00301	CcSEcCtD
Tazarotene—Dermatitis bullous—Dexamethasone—systemic lupus erythematosus	0.000274	0.00294	CcSEcCtD
Tazarotene—Dermatitis bullous—Betamethasone—systemic lupus erythematosus	0.000274	0.00294	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—systemic lupus erythematosus	0.00027	0.0029	CcSEcCtD
Tazarotene—Skin exfoliation—Methotrexate—systemic lupus erythematosus	0.00025	0.00269	CcSEcCtD
Tazarotene—RARA—Adipogenesis—RXRA—systemic lupus erythematosus	0.000247	0.00425	CbGpPWpGaD
Tazarotene—Dry skin—Dexamethasone—systemic lupus erythematosus	0.00024	0.00257	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—systemic lupus erythematosus	0.00024	0.00257	CcSEcCtD
Tazarotene—Haemoglobin—Cyclosporine—systemic lupus erythematosus	0.00024	0.00257	CcSEcCtD
Tazarotene—Discomfort—Azathioprine—systemic lupus erythematosus	0.00024	0.00257	CcSEcCtD
Tazarotene—Haemorrhage—Cyclosporine—systemic lupus erythematosus	0.000238	0.00256	CcSEcCtD
Tazarotene—Haemoglobin—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.00251	CcSEcCtD
Tazarotene—Haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.00249	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000229	0.00395	CbGpPWpGaD
Tazarotene—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.000229	0.00246	CcSEcCtD
Tazarotene—Discomfort—Leflunomide—systemic lupus erythematosus	0.000226	0.00243	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.00022	0.00378	CbGpPWpGaD
Tazarotene—Haemoglobin—Prednisolone—systemic lupus erythematosus	0.000218	0.00234	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—systemic lupus erythematosus	0.000217	0.00233	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000216	0.00372	CbGpPWpGaD
Tazarotene—Haemoglobin—Hydrocortisone—systemic lupus erythematosus	0.000213	0.00228	CcSEcCtD
Tazarotene—Haemorrhage—Hydrocortisone—systemic lupus erythematosus	0.000212	0.00227	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	0.000209	0.0036	CbGpPWpGaD
Tazarotene—Dry skin—Prednisone—systemic lupus erythematosus	0.000209	0.00224	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000207	0.00357	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000202	0.00347	CbGpPWpGaD
Tazarotene—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000201	0.00215	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.0002	0.00215	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000199	0.00214	CcSEcCtD
Tazarotene—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000199	0.00213	CcSEcCtD
Tazarotene—RARA—Adipogenesis—FAS—systemic lupus erythematosus	0.000195	0.00336	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.00019	0.00326	CbGpPWpGaD
Tazarotene—Erythema—Prednisolone—systemic lupus erythematosus	0.000189	0.00203	CcSEcCtD
Tazarotene—Pain—Leflunomide—systemic lupus erythematosus	0.000188	0.00201	CcSEcCtD
Tazarotene—Erythema—Hydrocortisone—systemic lupus erythematosus	0.000184	0.00198	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000182	0.00195	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000182	0.00195	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000182	0.00313	CbGpPWpGaD
Tazarotene—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000181	0.00194	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000181	0.00194	CcSEcCtD
Tazarotene—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000175	0.00187	CcSEcCtD
Tazarotene—Erythema—Triamcinolone—systemic lupus erythematosus	0.000174	0.00186	CcSEcCtD
Tazarotene—RARG—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000174	0.00299	CbGpPWpGaD
Tazarotene—Erythema—Methylprednisolone—systemic lupus erythematosus	0.000173	0.00186	CcSEcCtD
Tazarotene—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00017	0.00183	CcSEcCtD
Tazarotene—Oedema—Cyclosporine—systemic lupus erythematosus	0.000169	0.00182	CcSEcCtD
Tazarotene—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00177	CcSEcCtD
Tazarotene—Discomfort—Prednisolone—systemic lupus erythematosus	0.000159	0.0017	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—systemic lupus erythematosus	0.000158	0.0017	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000158	0.00169	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—systemic lupus erythematosus	0.000158	0.00169	CcSEcCtD
Tazarotene—Erythema—Betamethasone—systemic lupus erythematosus	0.000158	0.00169	CcSEcCtD
Tazarotene—RARG—Gene Expression—MTA2—systemic lupus erythematosus	0.000157	0.0027	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—systemic lupus erythematosus	0.000156	0.00269	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000156	0.00268	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000155	0.00267	CbGpPWpGaD
Tazarotene—Pruritus—Leflunomide—systemic lupus erythematosus	0.000155	0.00167	CcSEcCtD
Tazarotene—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000155	0.00166	CcSEcCtD
Tazarotene—Oedema—Prednisolone—systemic lupus erythematosus	0.000154	0.00165	CcSEcCtD
Tazarotene—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000151	0.00161	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.00015	0.00161	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.00015	0.00258	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000149	0.00257	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000149	0.00257	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000149	0.00256	CbGpPWpGaD
Tazarotene—Rash—Azathioprine—systemic lupus erythematosus	0.000147	0.00157	CcSEcCtD
Tazarotene—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000146	0.00157	CcSEcCtD
Tazarotene—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000146	0.00157	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000146	0.00156	CcSEcCtD
Tazarotene—Pain—Cyclosporine—systemic lupus erythematosus	0.000145	0.00155	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000144	0.00247	CbGpPWpGaD
Tazarotene—Oedema—Triamcinolone—systemic lupus erythematosus	0.000142	0.00152	CcSEcCtD
Tazarotene—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.00152	CcSEcCtD
Tazarotene—RARB—Gene Expression—MTA2—systemic lupus erythematosus	0.000141	0.00242	CbGpPWpGaD
Tazarotene—Rash—Leflunomide—systemic lupus erythematosus	0.000138	0.00148	CcSEcCtD
Tazarotene—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000138	0.00148	CcSEcCtD
Tazarotene—Erythema—Prednisone—systemic lupus erythematosus	0.000137	0.00147	CcSEcCtD
Tazarotene—RXRB—Gene Expression—MTA2—systemic lupus erythematosus	0.000135	0.00232	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MTA2—systemic lupus erythematosus	0.000135	0.00232	CbGpPWpGaD
Tazarotene—Discomfort—Betamethasone—systemic lupus erythematosus	0.000133	0.00142	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000133	0.00142	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000132	0.00142	CcSEcCtD
Tazarotene—Pain—Prednisolone—systemic lupus erythematosus	0.000132	0.00141	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000132	0.00141	CcSEcCtD
Tazarotene—Pain—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00138	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—systemic lupus erythematosus	0.000129	0.00138	CcSEcCtD
Tazarotene—Oedema—Betamethasone—systemic lupus erythematosus	0.000129	0.00138	CcSEcCtD
Tazarotene—Pain—Triamcinolone—systemic lupus erythematosus	0.000121	0.0013	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.00012	0.00206	CbGpPWpGaD
Tazarotene—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00012	0.00129	CcSEcCtD
Tazarotene—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00125	CcSEcCtD
Tazarotene—Discomfort—Prednisone—systemic lupus erythematosus	0.000115	0.00124	CcSEcCtD
Tazarotene—Erythema—Methotrexate—systemic lupus erythematosus	0.000115	0.00123	CcSEcCtD
Tazarotene—Oedema—Prednisone—systemic lupus erythematosus	0.000112	0.0012	CcSEcCtD
Tazarotene—Pain—Dexamethasone—systemic lupus erythematosus	0.00011	0.00118	CcSEcCtD
Tazarotene—Pain—Betamethasone—systemic lupus erythematosus	0.00011	0.00118	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.00011	0.00189	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000107	0.00185	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CDKN1A—systemic lupus erythematosus	0.000107	0.00185	CbGpPWpGaD
Tazarotene—Rash—Cyclosporine—systemic lupus erythematosus	0.000107	0.00115	CcSEcCtD
Tazarotene—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000107	0.00114	CcSEcCtD
Tazarotene—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000106	0.00114	CcSEcCtD
Tazarotene—RARG—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000106	0.00182	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000105	0.00181	CbGpPWpGaD
Tazarotene—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00112	CcSEcCtD
Tazarotene—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00112	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000103	0.00177	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000103	0.00177	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SNRPB—systemic lupus erythematosus	0.000103	0.00177	CbGpPWpGaD
Tazarotene—Pruritus—Triamcinolone—systemic lupus erythematosus	0.0001	0.00108	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00107	CcSEcCtD
Tazarotene—Rash—Prednisolone—systemic lupus erythematosus	9.72e-05	0.00104	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—systemic lupus erythematosus	9.71e-05	0.00104	CcSEcCtD
Tazarotene—Discomfort—Methotrexate—systemic lupus erythematosus	9.65e-05	0.00103	CcSEcCtD
Tazarotene—RARB—Gene Expression—TNFSF13—systemic lupus erythematosus	9.51e-05	0.00164	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	9.51e-05	0.00164	CbGpPWpGaD
Tazarotene—Rash—Hydrocortisone—systemic lupus erythematosus	9.49e-05	0.00102	CcSEcCtD
Tazarotene—Dermatitis—Hydrocortisone—systemic lupus erythematosus	9.48e-05	0.00102	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	9.42e-05	0.00162	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	9.42e-05	0.00162	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SNRPB—systemic lupus erythematosus	9.21e-05	0.00158	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TNFSF13—systemic lupus erythematosus	9.12e-05	0.00157	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TNFSF13—systemic lupus erythematosus	9.12e-05	0.00157	CbGpPWpGaD
Tazarotene—Pruritus—Dexamethasone—systemic lupus erythematosus	9.1e-05	0.000976	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—systemic lupus erythematosus	9.1e-05	0.000976	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	9.03e-05	0.00155	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	9.03e-05	0.00155	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	9.03e-05	0.00155	CbGpPWpGaD
Tazarotene—Rash—Triamcinolone—systemic lupus erythematosus	8.94e-05	0.000958	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—systemic lupus erythematosus	8.93e-05	0.000958	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	8.92e-05	0.00153	CbGpPWpGaD
Tazarotene—Rash—Methylprednisolone—systemic lupus erythematosus	8.92e-05	0.000956	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—systemic lupus erythematosus	8.91e-05	0.000955	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.9e-05	0.00153	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—systemic lupus erythematosus	8.88e-05	0.00153	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SNRPB—systemic lupus erythematosus	8.83e-05	0.00152	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SNRPB—systemic lupus erythematosus	8.83e-05	0.00152	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	8.56e-05	0.00147	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	8.55e-05	0.00147	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—VDR—systemic lupus erythematosus	8.53e-05	0.00147	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	8.43e-05	0.00145	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.31e-05	0.00143	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—systemic lupus erythematosus	8.29e-05	0.00143	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	8.25e-05	0.00142	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.23e-05	0.00142	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—VDR—systemic lupus erythematosus	8.18e-05	0.00141	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	8.18e-05	0.00141	CbGpPWpGaD
Tazarotene—Rash—Betamethasone—systemic lupus erythematosus	8.11e-05	0.00087	CcSEcCtD
Tazarotene—Rash—Dexamethasone—systemic lupus erythematosus	8.11e-05	0.00087	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.1e-05	0.000869	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—systemic lupus erythematosus	8.1e-05	0.000869	CcSEcCtD
Tazarotene—Pain—Methotrexate—systemic lupus erythematosus	8e-05	0.000858	CcSEcCtD
Tazarotene—Pruritus—Prednisone—systemic lupus erythematosus	7.92e-05	0.00085	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.89e-05	0.00136	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.83e-05	0.00135	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	7.68e-05	0.00132	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.51e-05	0.00129	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.42e-05	0.00128	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	7.4e-05	0.00127	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	7.36e-05	0.00127	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	7.36e-05	0.00127	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.11e-05	0.00122	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	7.09e-05	0.00122	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	7.09e-05	0.00122	CbGpPWpGaD
Tazarotene—Rash—Prednisone—systemic lupus erythematosus	7.06e-05	0.000757	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—systemic lupus erythematosus	7.05e-05	0.000757	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.81e-05	0.00117	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—systemic lupus erythematosus	6.69e-05	0.00115	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	6.63e-05	0.00114	CbGpPWpGaD
Tazarotene—Pruritus—Methotrexate—systemic lupus erythematosus	6.62e-05	0.00071	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.53e-05	0.00112	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.36e-05	0.00109	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.31e-05	0.00108	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.1e-05	0.00105	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.95e-05	0.00102	CbGpPWpGaD
Tazarotene—Rash—Methotrexate—systemic lupus erythematosus	5.9e-05	0.000633	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—systemic lupus erythematosus	5.9e-05	0.000632	CcSEcCtD
Tazarotene—RARG—Gene Expression—JUNB—systemic lupus erythematosus	5.77e-05	0.000992	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.7e-05	0.000981	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.7e-05	0.000981	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—JUNB—systemic lupus erythematosus	5.17e-05	0.00089	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RXRA—systemic lupus erythematosus	5.06e-05	0.00087	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—JUNB—systemic lupus erythematosus	4.96e-05	0.000853	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—JUNB—systemic lupus erythematosus	4.96e-05	0.000853	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	4.73e-05	0.000813	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—VDR—systemic lupus erythematosus	4.58e-05	0.000788	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RXRA—systemic lupus erythematosus	4.53e-05	0.00078	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RXRA—systemic lupus erythematosus	4.35e-05	0.000748	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RXRA—systemic lupus erythematosus	4.35e-05	0.000748	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—systemic lupus erythematosus	4.12e-05	0.000709	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—VDR—systemic lupus erythematosus	4.11e-05	0.000706	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—VDR—systemic lupus erythematosus	3.94e-05	0.000677	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—VDR—systemic lupus erythematosus	3.94e-05	0.000677	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—systemic lupus erythematosus	3.7e-05	0.000636	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—systemic lupus erythematosus	3.54e-05	0.00061	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—systemic lupus erythematosus	3.54e-05	0.00061	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—systemic lupus erythematosus	3.19e-05	0.000549	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—systemic lupus erythematosus	2.86e-05	0.000492	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—systemic lupus erythematosus	2.75e-05	0.000472	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—systemic lupus erythematosus	2.75e-05	0.000472	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.81e-05	0.000312	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.44e-05	0.000248	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.15e-05	0.000197	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.03e-05	0.000177	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.01e-06	0.000155	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	8.08e-06	0.000139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.5e-06	0.000129	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	5.1e-06	8.78e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	4.59e-06	7.89e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	4.39e-06	7.55e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	4.01e-06	6.9e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	3.34e-06	5.74e-05	CbGpPWpGaD
